Latest filing published 14 Dec 2018 for BIOLASE, INC, €4,704.
Filing timeline
BuySaleInsider track record
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Garrett Sato: trading record in brief
Garrett Sato is a declared insider of Biolase, Inc, with filings sourced from SEC (Form 4). We count 3 filings; the first trade dates from 10 August 2018 and the latest from 13 December 2018.
The open-market record is one-sided, with 3 purchases worth €16k and not one sale. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket.
A typical purchase (the median) is worth €5,366. Clusters matter here: 3 out of 3 purchases overlapped with buying by a colleague within 30 days. Purchases made close together by different insiders form what is called a cluster.
The newest entry dates from 14 December 2018: an open-market purchase of €4,704, in Biolase, Inc. The median gap between a trade and its publication by SEC (Form 4) is 1 day. The legal deadline for a Form 4 is two business days after the transaction. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Garrett Sato
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 5,000 shares@ US$1.0729.4% of flowCommon StockSEC:0001209191-18-062840:0Canonical exit: 13 Mar 2019 (T+90)
- 5,000 shares@ US$1.2233.5% of flowCommon StockSEC:0001209191-18-060321:0Canonical exit: 27 Feb 2019 (T+90)
- 5,000 shares@ US$1.3737.1% of flowCommon StockSEC:0001209191-18-046673:0Canonical exit: 8 Nov 2018 (T+90)
3 of 3 declarations
